News | Cardiovascular Ultrasound | February 26, 2018

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

WASE Normal Values Study will assess whether current recommended normal values for heart dimensions and function are adequate, develop normal values for novel modalities like 3-D and strain

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joining efforts in the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. This study is bringing together the scientific cardiovascular ultrasound community from around the world to better understand if the current recommended normal values for heart dimensions and function in subjects from different races and countries are similar or different. In addition, normal values for novel echocardiography modalities such as 3-D and strain will be established.

Principal investigators Roberto M. Lang, M.D., FASE, University of Chicago Medical Center, and Federico M. Asch, M.D., FASE, MedStar Health Research Institute in Washington, D.C.,announced that the WASE study has enrolled the landmark number of 1,000 subjects. Asch said, “This represents over 50 percent of our target. We are hoping to complete enrollment by the end of this year. Individuals from six continents have been enrolled and initial preliminary findings will be presented at the ASE 2018 Scientific Sessions in Nashville this June.” Final results are expected to be available in 2019.

The WASE Normal Values Study entails the acquisition of complete 2-D and 3-D echocardiograms in 100 healthy individuals of both genders and across a wide range of ages in each of 17 countries. All echoes will be analyzed in collaboration with MedStar Health and the University of Chicago. The clinical usefulness of echocardiography is based on the detection of abnormalities, which relies on the accurate definition of “normality” across different countries or races. Currently, available echocardiographic “reference values” that define “normality” are mostly based on cross-sectional observations of Caucasians from the U.S. and Europe.

Robin Wiegerink, CEO of ASE said, “This study provides unique opportunities to interact with our global partners to facilitate scientific collaborations and strengthen relationships, with the goal of improved patient care. The ASE International Alliance Partners program was developed to foster this kind of interaction and create synergies that could be replicated in future standardization projects.”

The WASE Normal Values Study is being funded by the American Society of Echocardiography Foundation and its donors, and with in-kind support from sponsors Tomtec Imaging Systems, Medidata, MedStar Health and University of Chicago.

For more information: www.asecho.org

 

Related Content

New echo technology and products at the 2018 ASE meeting.
Feature | ASE | June 22, 2018
More than 60 companies and organizations are displaying their latest products and services at the 2018 American Socie
GE Healthcare Vivid T8 cardiac ultrasound, highlights from the American Society of Echo ASE 2017
Feature | ASE | June 26, 2017
June 26, 2017 — Here is a list of some key clinical presentations and video interviews with cardiac ultrasound though
Videos | ASE | June 30, 2016
DAIC/ITN editor Dave Fornell shares some of the innovative new technologies on the show floor of the American Society
Overlay Init